Literature DB >> 36203291

Spinal Cord Injury Provoked Neuropathic Pain and Spasticity, and Their GABAergic Connection.

Ankita Bhagwani1, Manjeet Chopra1, Hemant Kumar1.   

Abstract

Traumatic spinal cord injury (SCI) is the devastating neurological damage to the spinal cord that becomes more complicated in the secondary phase. The secondary injury comes with inevitable long-lasting complications, such as chronic neuropathic pain (CNP) and spasticity which interfere with day to day activities of SCI patients. Mechanisms underlying CNP post-SCI are complex and remain refractory to current medical treatment. Due to the damage, extensive inhibitory, excitatory tone dysregulation causes maladaptive synaptic transmissions, further altering the nociceptive and nonnociceptive pathways. Excitotoxicity mediated GABAergic cell loss, downregulation of glutamate acid decarboxylase enzyme, upregulation of gamma-aminobutyric acid (GABA) transporters, overactivation of glutamate receptors are some of the key evidence for hypoactive inhibitory tone contributing to CNP and spasticity post-SCI. Restoring the inhibitory GABAergic tone and preventing damage-induced excitotoxicity by employing various strategies provide neuroprotective and analgesic effects. The present article will discuss CNP and spasticity post-SCI, understanding their pathophysiological mechanisms, especially GABA-glutamate-related mechanisms, therapeutic interventions targeting them, and progress regarding how regulating the excitatory-inhibitory tone may lead to more targeted treatments for these distressing complications. Taking background knowledge of GABAergic analgesia and recent advancements, we aim to highlight how far we have reached in promoting inhibitory GABAergic tone for SCI-CNP and spasticity.

Entities:  

Keywords:  Chronic neuropathic pain; Dorsal horn; Glutamate; Hyperexcitability; Spasticity; Spinal cord injury

Year:  2022        PMID: 36203291      PMCID: PMC9537837          DOI: 10.14245/ns.2244368.184

Source DB:  PubMed          Journal:  Neurospine        ISSN: 2586-6591


  156 in total

Review 1.  The dark side of neuroplasticity.

Authors:  Arthur Brown; Lynne C Weaver
Journal:  Exp Neurol       Date:  2011-11-12       Impact factor: 5.330

2.  Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats.

Authors:  Araceli Diaz-Ruiz; Hermelinda Salgado-Ceballos; Sergio Montes; Valente Maldonado; Luis Tristan; Mireya Alcaraz-Zubeldia; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

Review 3.  Unconventional GABA release: mechanisms and function.

Authors:  Ursula Koch; Anna K Magnusson
Journal:  Curr Opin Neurobiol       Date:  2009-04-16       Impact factor: 6.627

4.  Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Lesley C Fisher; Violetta McGaughy; Erin E Longbrake; Phillip G Popovich; D Michele Basso
Journal:  Exp Neurol       Date:  2008-04-20       Impact factor: 5.330

5.  Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury.

Authors:  A D Bennett; A W Everhart; C E Hulsebosch
Journal:  Brain Res       Date:  2000-03-17       Impact factor: 3.252

6.  Enzyme activities involved in the glutamate-glutamine cycle are altered to reduce glutamate after spinal cord injury in rats.

Authors:  Araceli Diaz-Ruiz; Sergio Montes; Hermelinda Salgado-Ceballos; Valente Maldonado; Liliana Rivera-Espinosa; Camilo Ríos
Journal:  Neuroreport       Date:  2016-12-14       Impact factor: 1.837

7.  Early delivery and prolonged treatment with nimodipine prevents the development of spasticity after spinal cord injury in mice.

Authors:  Maite Marcantoni; Andrea Fuchs; Peter Löw; Dusan Bartsch; Ole Kiehn; Carmelo Bellardita
Journal:  Sci Transl Med       Date:  2020-04-15       Impact factor: 17.956

8.  Ketamine for acute neuropathic pain in patients with spinal cord injury.

Authors:  Kyongsong Kim; Masahiro Mishina; Rinko Kokubo; Takao Nakajima; Daijiro Morimoto; Toyohiko Isu; Shiro Kobayashi; Akira Teramoto
Journal:  J Clin Neurosci       Date:  2013-04-22       Impact factor: 1.961

Review 9.  Regional Hyperexcitability and Chronic Neuropathic Pain Following Spinal Cord Injury.

Authors:  Jonghoon Kang; Steve S Cho; Hee Young Kim; Bong Hyo Lee; Hee Jung Cho; Young S Gwak
Journal:  Cell Mol Neurobiol       Date:  2020-01-18       Impact factor: 5.046

Review 10.  Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury.

Authors:  Young S Gwak; Claire E Hulsebosch; Joong Woo Leem
Journal:  Neural Plast       Date:  2017-08-29       Impact factor: 3.599

View more
  1 in total

1.  The Role of GABA in Spinal Cord Injury.

Authors:  Xue Yao
Journal:  Neurospine       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.